Manuscripts
Showing 1595 manuscripts.
Toll-like receptor ligans induce human T cell activation and death, a model for HIV pathogenesis
Citation
Nicholas T. Funderburg, Ph.D., Angel A. Luciano, Wei Jiang, M.D., M.S., Benigno Rodriguez, M.D., Scott F. Sieg, Ph.D., Michael M. Lederman, M.D. Toll-like receptor ligans induce human T cell activation and death, a model for HIV pathogenesis. Public Library of Science One. 2008 Apr 01; 3(4):1-7. PMCID: PMC2271052.Year
2008
Journal
Public Library of Science One
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals
Citation
Nancy C. Connolly, M.D., M.P.H., Theresa Whiteside, Ph.D., Cara C. Wilson, M.D., Venkatswarlu Kondragunta, Charles Rinaldo, Jr., Ph.D., Sharon A. Riddler, M.D., M.P.H. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Clinical and Vaccine Immunology. 2008 Feb 01; 15(2):284-92. PMCID: PMC2238066.Year
2008
Journal
Clinical and Vaccine Immunology
Persistence of transmitted drug resistance among subjects with primary HIV infection
Citation
Susan J. Little, M.D., Simon D. W. Frost, D.Phil., Joseph K. Wong, M.D., Davey M. Smith, M.D., Sergei L. Kosakovsky Pond, Ph.D., Caroline Ignacio, Neil Parkin, Christos J. Petropoulos, Ph.D., Douglas D. Richman, M.D. Persistence of transmitted drug resistance among subjects with primary HIV infection. Journal of Virology. 2008 Jun 01; 82(11):5510-18. PMCID: PMC2395184.Year
2008
Journal
Journal of Virology
Estimating selection pressures on HIV-1 using phylogenetic likelihood models
Citation
Sergei L. Kosakovsky Pond, Ph.D., Art Poon, Selene Zarate, Davey M. Smith, M.D., Susan J. Little, M.D., Satish K. Pillai, Ronald J. Ellis, M.D.,Ph.D., Joseph K. Wong, M.D., Andrew Leigh-Brown, Ph.D., Douglas D. Richman, M.D., Simon D. W. Frost, D.Phil. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Statistics In Medicine. 2008 Oct 15; 27(23):4779-89. PMCID: PMC2634745.Year
2008
Journal
Statistics In Medicine
Evaluation of high protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial
Citation
Fred Richard Sattler, M.D., Natasa Rajicic, M.S., Kathleen Mulligan, Ph.D., Kevin E. Yarasheski, Ph.D., Susan L. Koletar, M.D., Andrew R. Zolopa, M.D., Beverly L. Alston-Smith, M.D., Robert Zackin, Sc.D., Bruce Bistrian, M.D., Ph.D. Evaluation of high protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. American Journal of Clinical Nutrition. 2008 Nov 01; 88(5):1313-21. PMCID: PMC2797483.Year
2008
Journal
American Journal of Clinical Nutrition
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women
Citation
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. American Journal of Clinical Nutrition. 2008 Jun 02; 87(6):1639-49. PMID: 18541551; PMCID: PMC2474657.Year
2008
Journal
American Journal of Clinical Nutrition
Lopinavir exposure with an increased dose during pregnancy
Citation
Mark Mirochnick, Brookie M Best, Alice M Stek, Edmund Capparelli, ChengCheng Hu, Sandra K Burchett, Diane T Holland, Elizabeth Smith, Sreedhar Gaddipati, Jennifer S Read, PACTG 1026s Study Team. Lopinavir exposure with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2008 Dec 15; 49(5):485-91. PMID: 18989231; PMCID: PMC3912695.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095
Citation
Bruce R. Schackman, Ph.D., Heather Ribaudo, Ph.D., Amy Krambrink, M.S., Valery Hughes, F.N.P., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H. Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095. Journal of Acquired Immune Deficiency Syndromes. 2007 Dec 15; 46(5):547-54. PMID: 18193496.Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients
Citation
Rahul P. Bakshi, Fayez Hamzeh, M.D., Ph.D., Ian Frank, M.D., Joseph J. Eron, Jr., M.D., Ronald J. Bosch, Ph.D., Susan L Rosenkranz, Ph.D., Yoninah S. Cramer, M.S., Michael Ussery, Ph.D., Charles Flexner, M.D. Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. AIDS Research and Human Retroviruses. 2007 Nov 01; 23(11):1360-5. PMID: 18184078.Year
2007
Journal
AIDS Research and Human Retroviruses
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
Citation
Giovanni Schifitto, M.D., Jiameng Zhang, Ph.D., Scott Evans, Ph.D., Ned Sacktor, M.D., David M. Simpson, M.D., Linda L. Millar, B.S., Vivian (Lang) M. Hung, M.P.H., Eric N. Miller, Ph.D., Elizabeth (Betsy) Smith, M.D., Ronald J. Ellis, M.D.,Ph.D., Victor G. Valcour, M.D., Elyse J. Singer, M.D., Christina M. Marra, M.D., Dennis Kolson, M.D., Ph.D., James Weihe, M.D., Rory P. Remmel, Ph.D., David Katzenstein, M.D., David B. Clifford, M.D. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology. 2007 Sep 25; 69(13):1314-21. PMID: 17652642.Year
2007
Journal
Neurology